Early Catheter-directed Treatment of High Risk Pulmonary Embolism

Recruiting N/A Interventional Study
Pulmonary Embolism Acute Massive
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
210 (estimated)
Sponsor
Leipzig Heart Science gGmbH · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Prospective, multicenter, open label, randomized controlled clinical trial to compare the effects of an early catheter-directed treatment plus conventional care with conventional care in patients with high-risk pulmonary embolism

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Pulmonary embolism as confirmed by CT angiogram with high mortality risk as defined by ESC guidelines: a) One of the following: i. Cardiac arrest or ii. obstructive shock (systolic BP \<90 mmHg or vasopressors required to achieve a BP ≥90 mmHg despite an adequate filling …
Contacts

Karl Fengler, MD, Assoc. Prof.

+49 341 865-1426

karl.fengler@medizin.uni-leipzig.de

CONTACT

Holger Thiele, MD, Prof. Dr.

holger.thiele@medizin.uni-leipzig.de

CONTACT